Chao Lu

Huainan, 232001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Extracellular matrix stiffness in chronic liver disease: From mechanisms to treatments.

Extracellular matrix stiffness in chronic liver disease: From mechanisms to treatments.

Journal: Biochemical pharmacology

Published: May 18, 2026

Epigenetic Regulation in Liver Fibrosis: Focus on the Chromatin Accessibility Landscape.

Epigenetic Regulation in Liver Fibrosis: Focus on the Chromatin Accessibility Landscape.

Journal: European journal of pharmacology

Published: April 16, 2026

Tuspetinib enhances the activity of polymyxin B by inhibiting the GlcNAc6P deacetylase.

Tuspetinib enhances the activity of polymyxin B by inhibiting the GlcNAc6P deacetylase.

Journal: The Journal of antibiotics

Published: January 08, 2026

Reply to letter to the editor questions and comments on "ALKBH5 attenuates mitochondrial fission and ameliorates liver fibrosis by reducing Drp1 methylation".

Reply to letter to the editor questions and comments on "ALKBH5 attenuates mitochondrial fission and ameliorates liver fibrosis by reducing Drp1 methylation".

Journal: Pharmacological research

Published: January 06, 2026

Investigating the Role of ALPK2 in Endometrial Cancer Progression: From Biological Function to Clinical Translation.

Investigating the Role of ALPK2 in Endometrial Cancer Progression: From Biological Function to Clinical Translation.

Journal: Reproductive sciences (Thousand Oaks, Calif.)

Published: December 24, 2025

Targeting FOSL1-KCa3.1 inhibits ferroptosis and cartilage destruction by suppressing mitochondrial hyperfusion.

Targeting FOSL1-KCa3.1 inhibits ferroptosis and cartilage destruction by suppressing mitochondrial hyperfusion.

Journal: Acta pharmacologica Sinica

Published: December 19, 2025

Peroxiredoxin 6: A Regulatory Target in Cellular Senescence and Age-Related Diseases.

Peroxiredoxin 6: A Regulatory Target in Cellular Senescence and Age-Related Diseases.

Journal: Antioxidants & redox signaling

Published: June 11, 2025

Occupational nanoparticles: major sources, physicochemical properties, multi-organ toxic effects, and associated mechanisms.

Occupational nanoparticles: major sources, physicochemical properties, multi-organ toxic effects, and associated mechanisms.

Journal: Toxicology mechanisms and methods

Published: May 21, 2025

Novel insights on post-translational modifications of nucleic acid methylation proteins in hepatic fibrosis.

Novel insights on post-translational modifications of nucleic acid methylation proteins in hepatic fibrosis.

Journal: Pharmacological research

Published: April 22, 2025

Association between combined exposure to underground air pollutants and hypertension in coal miners: a cross-sectional study.

Association between combined exposure to underground air pollutants and hypertension in coal miners: a cross-sectional study.

Journal: BMC public health

Published: March 25, 2025

Novel epitranscriptomic and epigenetic therapeutic strategies and targets for ferroptosis in liver fibrosis.

Novel epitranscriptomic and epigenetic therapeutic strategies and targets for ferroptosis in liver fibrosis.

Journal: European journal of pharmacology

Published: November 17, 2024

iMeta Conference 2024: Building an innovative scientific research ecosystem for microbiome and One Health.

iMeta Conference 2024: Building an innovative scientific research ecosystem for microbiome and One Health.

Journal: iMeta

Published: October 24, 2024

Showing 1-12 of 24

Last Updated: 09/26/2026